Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and fiscal year June 20, 2022. For the first half, the company expects net sales of ¥76,800 million, operating income was ¥3,100 million and net income attributable to owners of parent of ¥2,260 million or ¥148.91 per share. For the year ending June 20, 2021, the company expects net sales of ¥160,000 million, operating income was ¥6,500 million and net income attributable to owners of parent of ¥4,720 million or ¥310.99 per share.